Zinc Oxide - NDC Database (Page 69)
3,799 records found
Page:
63931-4453 Jan 20, 2021
Wl-aad-z-w-1053 132 mg/ml Topical Lotion by Nanophase Technologies Corporation
Wl-aad-z-w-1053 132 mg/ml Topical Lotion by Nanophase Technologies Corporation
63931-4454 Jan 20, 2021
Wl-aad-z-w-1054 132 mg/ml Topical Lotion by Nanophase Technologies Corporation
Wl-aad-z-w-1054 132 mg/ml Topical Lotion by Nanophase Technologies Corporation
63931-4455 Jan 20, 2021
Wl-aad-z-w-1055 132 mg/ml Topical Lotion by Nanophase Technologies Corporation
Wl-aad-z-w-1055 132 mg/ml Topical Lotion by Nanophase Technologies Corporation
63931-4456 Jan 20, 2021
Wl-aad-z-w-1056 132 mg/ml Topical Lotion by Nanophase Technologies Corporation
Wl-aad-z-w-1056 132 mg/ml Topical Lotion by Nanophase Technologies Corporation
63931-4457 Jan 20, 2021
Wl-aad-z-w-1057 132 mg/ml Topical Lotion by Nanophase Technologies Corporation
Wl-aad-z-w-1057 132 mg/ml Topical Lotion by Nanophase Technologies Corporation
63931-4458 Jan 20, 2021
Wl-aad-z-w-1058 132 mg/ml Topical Lotion by Nanophase Technologies Corporation
Wl-aad-z-w-1058 132 mg/ml Topical Lotion by Nanophase Technologies Corporation
63931-4459 Jan 20, 2021
Wl-aad-z-w-1059 132 mg/ml Topical Lotion by Nanophase Technologies Corporation
Wl-aad-z-w-1059 132 mg/ml Topical Lotion by Nanophase Technologies Corporation
63931-4460 Jan 20, 2021
Wl-aad-z-w-1060 132 mg/ml Topical Lotion by Nanophase Technologies Corporation
Wl-aad-z-w-1060 132 mg/ml Topical Lotion by Nanophase Technologies Corporation
63931-4463 May 24, 2021
Wl-aab-z-w-1117 135.6 mg/ml Topical Lotion by Nanophase Technologies Corporation
Wl-aab-z-w-1117 135.6 mg/ml Topical Lotion by Nanophase Technologies Corporation
63931-4464 Jun 27, 2021
Wl-aab-z-w-1118 135.6 mg/ml Topical Lotion by Nanophase Technologies Corporation
Wl-aab-z-w-1118 135.6 mg/ml Topical Lotion by Nanophase Technologies Corporation
63931-4465 Oct 04, 2021
Wl-aae-z-o-1039 132 mg/ml Topical Lotion by Nanophase Technologies Corporation
Wl-aae-z-o-1039 132 mg/ml Topical Lotion by Nanophase Technologies Corporation
63931-4466 Apr 18, 2022
Wl-aad-z-w-1020 132 mg/ml Topical Lotion by Nanophase Technologies Corporation
Wl-aad-z-w-1020 132 mg/ml Topical Lotion by Nanophase Technologies Corporation
63931-4468 May 15, 2021
Wl-aab-z-w-1095 132 mg/ml Topical Lotion by Nanophase Technologies Corporation
Wl-aab-z-w-1095 132 mg/ml Topical Lotion by Nanophase Technologies Corporation
63931-4469 Mar 16, 2022
Wl-aae-z-o-1032 132 mg/ml Topical Lotion by Nanophase Technologies Corporation
Wl-aae-z-o-1032 132 mg/ml Topical Lotion by Nanophase Technologies Corporation
63931-4470 Mar 16, 2022
Wl-aaj-z-w-1138 12 mg/ml Topical Lotion by Nanophase Technologies Corporation
Wl-aaj-z-w-1138 12 mg/ml Topical Lotion by Nanophase Technologies Corporation
63931-4473 Feb 14, 2022
Wl-aad-z-w-1038 132 mg/ml Topical Lotion by Nanophase Technologies Corporation
Wl-aad-z-w-1038 132 mg/ml Topical Lotion by Nanophase Technologies Corporation
63931-4475 Apr 12, 2022
Wl-aad-z-w-1062 132 mg/ml Topical Lotion by Nanophase Technologies Corporation
Wl-aad-z-w-1062 132 mg/ml Topical Lotion by Nanophase Technologies Corporation
63931-4476 Apr 12, 2022
Wl-aad-z-w-1063 132 mg/ml Topical Lotion by Nanophase Technologies Corporation
Wl-aad-z-w-1063 132 mg/ml Topical Lotion by Nanophase Technologies Corporation
63931-4477 Apr 12, 2022
Wl-aad-z-w-1064 132 mg/ml Topical Lotion by Nanophase Technologies Corporation
Wl-aad-z-w-1064 132 mg/ml Topical Lotion by Nanophase Technologies Corporation
63931-4478 Apr 12, 2022
Wl-aad-z-w-1065 132 mg/ml Topical Lotion by Nanophase Technologies Corporation
Wl-aad-z-w-1065 132 mg/ml Topical Lotion by Nanophase Technologies Corporation
Page:
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.